These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 15078273)

  • 1. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar.
    Bhattarai NR; Van der Auwera G; Khanal B; De Doncker S; Rijal S; Das ML; Uranw S; Ostyn B; Praet N; Speybroeck N; Picado A; Davies C; Boelaert M; Dujardin JC
    Trop Med Int Health; 2009 Apr; 14(4):404-11. PubMed ID: 19228350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
    Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
    Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of direct agglutination test in seroepidemiological survey of Kala-azar in epidemic foci of Bihar.
    Sharma MC; Bimal S; Ranjan A; Das VN; Gupta AK; Kumar N; Kar SK
    J Commun Dis; 2000 Jun; 32(2):117-22. PubMed ID: 11198396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production.
    Chowdhury MS; al Masum A; al Karim E; Semiáo-Santos S; Rahman KM; Ar-Rashid H; el Harith A
    Arch Inst Pasteur Tunis; 1993; 70(3-4):333-44. PubMed ID: 7802488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a standardized direct agglutination test (DAT) for the diagnosis of visceral leishmaniasis in Kenya.
    Mbati PA; Githure JI; Kagai JM; Kirigi G; Kibati F; Wasunna K; Koech DK
    Ann Trop Med Parasitol; 1999 Oct; 93(7):703-10. PubMed ID: 10715698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal.
    Rijal S; Boelaert M; Regmi S; Karki BM; Jacquet D; Singh R; Chance ML; Chappuis F; Hommel M; Desjeux P; Van der Stuyft P; Le Ray D; Koirala S
    Trop Med Int Health; 2004 Jun; 9(6):724-9. PubMed ID: 15189464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW; Kager PA
    Trans R Soc Trop Med Hyg; 1991; 85(4):474-6. PubMed ID: 1755052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on IFAT, ELISA & DAT for serodiagnosis of visceral leishmaniasis in Bangladesh.
    Alam MJ; Rahman KM; Asna SM; Muazzam N; Ahmed I; Chowdhury MZ
    Bangladesh Med Res Counc Bull; 1996 Apr; 22(1):27-32. PubMed ID: 9037842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.
    Abdallah KA; Nour BY; Schallig HD; Mergani A; Hamid Z; Elkarim AA; Saeed OK; Mohamadani AA
    Trop Med Int Health; 2004 Oct; 9(10):1127-31. PubMed ID: 15482407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis in Nepal during 1980-2006.
    Joshi DD; Sharma M; Bhandari S
    J Commun Dis; 2006 Mar; 38(2):139-48. PubMed ID: 17370676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LD body-negative bone marrow cases of kala-azar in Dharan, Nepal.
    Karki P; Parija SC; Koirala S
    J Commun Dis; 1999 Dec; 31(4):261-2. PubMed ID: 10937305
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on human bone-marrow for Leishmania donovani.
    Rajendran P; Chatterjee SN; Gupta JB
    Indian J Pathol Microbiol; 1989 Oct; 32(4):282-5. PubMed ID: 2632416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient's blood.
    Pal S; Aggarwal G; Haldar A; Majumdar A; Majumdar HK; Duttagupta S
    Med Sci Monit; 2004 Jan; 10(1):MT1-5. PubMed ID: 14704640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.
    Khanal B; Picado A; Bhattarai NR; Van Der Auwera G; Das ML; Ostyn B; Davies CR; Boelaert M; Dujardin JC; Rijal S
    Parasitology; 2010 Sep; 137(11):1597-603. PubMed ID: 20459877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-epidemiological study of visceral leishmaniasis in Basrah, Southern Iraq.
    Gani ZH; Hassan MK; Jassim AM
    J Pak Med Assoc; 2010 Jun; 60(6):464-9. PubMed ID: 20527645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.